With the threat of pharmaceutical, medical device, and cosmetic product recalls ever-growing, manufacturers across these sectors should remain vigilant to product safety risks. In the first six months of 2023, both U.S. medical device and pharmaceutical industries have experienced significant rises in the level of recall activity – reaching three- and ten-year highs respectively. Furthermore, a closer inspection of the U.S. cosmetics sector reveals an alarming rise of Microbial contamination, which itself has hit a three-year high.
This session shares key recall insights and trends from the pharmaceutical, medical device and cosmetics sectors over the past five years. This session will also present best practices to help companies prepare themselves for handling product safety issues with essential advice and guidance on pre-planning (risk mitigation) and event management.
Learning Objectives:
understand the current landscape of medical devices, pharmaceuticals, and cosmetics
understand the considerations for designing a recall readiness plan
understand the considerations for designing a safety plan
